FedEx shares sink 5pct after profit outlook highlights tariff challenge
FedEx and rival United Parcel Service are considered economic bellwethers because they work with virtually every type of company around the world and spot business trends early.
US President Donald Trump's whiplash tariffs on China and pending deals with many other trading partners have forced many executives to put business plans and forecasts on hold until they have more certainty on product costs.
"The global demand environment remains volatile," FedEx CEO Raj Subramaniam said on an earnings webcast.
FedEx declined to issue full-year earnings and revenue forecasts, citing uncertainty over US trade policies, particularly with regard to China – the world's largest exporter.
FedEx is more exposed to China trade than rival UPS, whose shares were down less than one per cent. Washington slapped 145 per cent tariffs on China in April, freezing trade between the superpowers, before lowering them to 30 per cent in May.
Company executives said they expect Trump's tariff policies to continue pressuring the China-to-US trade air transit.
The biggest hit is from the Trump administration ending duty-free status for direct-to-consumer shipments from China-linked bargain sellers like Temu and Shein, FedEx Chief Customer Officer Brie Carere said.
As a result, the Memphis-based company forecast fiscal first-quarter adjusted profit of US$3.40 to US$4.00 per share. That was below analysts' estimates of US$4.06 per share, according to data compiled by LSEG.
The outlook overshadowed better-than-expected results for the fiscal fourth quarter that ended May 31, when the firm said cost cuts and improved export volumes pushed operating margins higher.
Adjusted profit in the May-ending quarter was US$1.46 billion, or US$6.07 per share, up from adjusted profit of US$1.34 billion, or US$5.41 per share, a year earlier.
Revenue rose to US$22.20 billion from US$22.10 billion. Analysts, on average, expected earnings of US$5.81 per share on revenue of US$21.80 billion, according to LSEG.
FedEx and UPS have been locked in a long battle for market share, with demand from manufacturers and other industrial customers stalled. Delivery profits have been squeezed as many customers downshifted from fast, pricey air services to slower, lower-cost ground shipments moved by trucks and trains.
Both FedEx and UPS used air volume from Temu, Shein and other retailers that shipped direct from factories in China to help replace lost business-to-business volume, but that ceased this spring.
After a botched attempt early this year, Trump's administration in May ended duty-free treatment for direct-to-consumer shipments valued at less than US$800 from China – stopping millions of air parcels from flooding into the United States.
FedEx said separately it planned to spin off its trucking business in June 2026.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
16 minutes ago
- Malay Mail
Quad launches minerals initiative to curb China's grip on critical supplies
WASHINGTON, July 2 — The United States, Japan, India and Australia pledged Tuesday to work together to ensure a stable supply of critical minerals, as worries grow over China's dominance in resources vital to new technologies. US Secretary of State Marco Rubio welcomed his counterparts from the so-called 'Quad' to Washington in a shift of focus to Asia, after spending much of his first six months on the wars in Ukraine and the Middle East and on President Donald Trump's domestic priorities such as migration. The four countries said in a joint statement that they were establishing the Quad Critical Minerals Initiative, aimed at 'collaborating on securing and diversifying' supply chains. They offered little detail but made clear the goal was to reduce reliance on China, which has used restrictions as leverage as the United States in turn curbs its access to semiconductors and as Trump threatens steep tariffs — including on Quad countries. 'Reliance on any one country for processing and refining critical minerals and derivative goods production exposes our industries to economic coercion, price manipulation and supply chain disruptions,' the statement said. The ministers were careful not to mention China by name but voiced 'serious concerns regarding dangerous and provocative actions' in the South China Sea and East China Sea that 'threaten peace and stability in the region.' China holds major reserves of several key minerals including the vast majority of the world's graphite, which is crucial for electric vehicles. In brief remarks alongside the other ministers, Rubio said he has 'personally been very focused' on diversifying supply chains and wanted 'real progress.' US refocus on Asia The four-way partnership was first conceived by late Japanese prime minister Shinzo Abe, who saw an alliance of democracies surrounding China — which has repeatedly alleged that the Quad is a way to contain it. Rubio had welcomed the Quad foreign ministers on January 21 in his first meeting after Trump's inauguration, seen as a sign the new administration would prioritise engagement with like-minded countries to counter China. But to the surprise of many, China has not topped the early agenda of Trump, who has spoken respectfully about his counterpart Xi Jinping and reached a truce with Beijing to avoid a wider trade war between the world's two largest economies. Trump is expected to travel to India later this year for a Quad summit. Both the Indian and Japanese foreign ministers said that they wanted the Quad to focus on a 'free and open Indo-Pacific' — a phrasing that is a veiled allusion to opposing Chinese dominance in Asia. 'It is essential that nations of the Indo-Pacific have the freedom of choice, so essential to make right decisions on development and security,' Indian Foreign Minister Subrahmanyam Jaishankar said. At Jaishankar's urging, the Quad condemned a May attack on the Indian side of Kashmir that killed mostly Hindu civilians and called for 'the perpetrators, organizers and financiers of this reprehensible act to be brought to justice without any delay.' India in May launched air strikes in Pakistan, which it blamed for the attack. Pakistan denied responsibility and responded with its own attacks on the Indian military. In a key concern for Japan, the Quad condemned North Korea for its 'destabilising launches' of missiles and insisted on its 'complete denuclearization.' Trump, in one of the most startling moves of his first term, met with North Korea's reclusive leader Kim Jong Un, helping ease tensions but producing no lasting agreement. Despite common ground on China, Quad members have differed on other hotspots, with the joint statement not mentioning Ukraine or Iran. India has maintained its long relationship with Russia despite the invasion of Ukraine, while both India and Japan also have historically enjoyed cordial ties with Iran. — AFP
The Star
37 minutes ago
- The Star
DOGE eats Musk? Billionaire entrepreneur's companies at risk as he reignites feud with Trump
WASHINGTON: Elon Musk may find out what happens when DOGE bites man. The billionaire SpaceX, Tesla and X owner who catapulted his zealous embrace of President Donald Trump into a powerful position, slashing government spending, now risks sweeping cuts to his own bottom line after resuming the feud that led to their very public bitter split last month. Musk's renewed heckling of Trump's big tax breaks and spending cuts bill, which passed the Senate on Tuesday, threatens to put billions of dollars of his government contracts in jeopardy if Trump retaliates. The rupture of their tenuous peace has resulted in a wobbling of the stock price of a market-moving company and led the president to muse about deporting Musk to his native South Africa. In a Frankenstein-style twist, as Musk volleyed fresh critiques about the cost of Trump's signature legislation, Trump mused Tuesday about turning Musk's Department of Government Efficiency back on its creator. "DOGE is the monster that might have to go back and eat Elon,' Trump told reporters as he left the White House for a tour of a new immigration detention center in Florida. Trump also suggested in an early morning social media post that if Musk lost his government contracts, he "would probably have to close up shop and head back home to South Africa.' Asked by a reporter later if he would deport Musk, Trump paused and said, "I don't know. We'll have to take a look.' In response, Musk wrote on X: "So tempting to escalate this. So, so tempting. But I will refrain for now.' Tesla and SpaceX did not respond to messages seeking comment about their CEO. Musk has called Trump's big bill a financial boondoggle for America that would kill jobs and bog down burgeoning industries. He's not limiting himself to harsh assessments on social media. On Monday, he threatened to reinsert himself into politics and try to oust every member of Congress who votes for the bill. "They will lose their primary next year if it is the last thing I do on this Earth,' Musk said in one post. In other posts, he branded Republicans "the PORKY PIG PARTY!!' and threatened to create a new political party. Trump has said Musk is actually irritated by the legislation's dramatic rollback of the Biden-era green energy tax breaks for electric vehicles and related technologies. Musk has denied this, but the rollback could hurt Tesla's finances. "Elon may get more subsidy than any human being in history, by far, and without subsidies, Elon would probably have to close up shop and head back home to South Africa,' Trump wrote in a post on his Truth Social media network. Musk became a US citizen in 2002, according to a biography of him by Walter Isaacson. It's unclear if Trump would take the extraordinary step of having the government explore the rare process of removing his citizenship, known as denaturalization. Musk's rocket and satellite company, SpaceX, is also in Trump's crosshairs. "No more Rocket launches, Satellites, or Electric Car Production, and our Country would save a FORTUNE,' Trump said in his post. "BIG MONEY TO BE SAVED!!!' SpaceX has received billions of federal dollars to help send astronauts into space and perform other work for NASA, including a contract to send a team from the space agency to the moon next year. But the most immediate fallout of their feud was the tumbling stock in Tesla, down 5.3% on Tuesday. Tesla stock's performance can have an outsize impact on the stock market index funds in which millions of Americans' 401(k)s have invested their retirement savings. The electric vehicle maker is one of the Magnificent Seven, the group of companies that includes Apple and Google parent Alphabet and that account for about a third of the value of the S&P 500. Musk's social media outbursts come at a delicate time for his car company. Tesla is just a week into its test run of its self-driving "robotaxi' service in Austin, Texas. Musk needs that test to succeed if he hopes to make good on his promise to investors that he will be able to quickly offer the service in other cities over the next few months. One possible hurdle to that: federal safety regulators. The National Highway Traffic Safety Administration requested information from Tesla last week after videos began circulating on social media of a few of its autonomous cabs in Austin driving erratically, including one heading down an opposing lane. That followed a NHTSA request for data last month on how the driverless taxis will perform in low-visibility conditions, which itself followed an investigation last year into 2.4 million Teslas equipped with full self-driving software after several accidents, including one that killed a pedestrian. Musk needs robotaxis to take off because Tesla's main business of selling cars is going poorly. Musk has acknowledged that boycotts by people angry with his political views have hurt sales, but he has largely blamed a less frightening, temporary factor: People are so excited about Tesla's forthcoming latest version of their Model Y SUV that they decided to hold off on purchases for a few months. But now that the new version is available, and sales are still tanking. Figures out last week showed sales in Europe plunged 28% in May over the prior year, the fifth month in a row of big drops. A new batch of sales data, including the US and other parts of the world, is coming out on Wednesday. The irony is that Musk's social media spat with Trump threatens his businesses from both sides. People won't buy his cars because of the memories of his friendship with Trump, and now that and his other businesses could get hurt because that friendship has soured. "In a bizzarro world, he's alienated both sides,' said Dan Ives, a Wedbush Securities financial analyst. "It seems impossible, but he's actually done it.' – AP
Malay Mail
an hour ago
- Malay Mail
Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha
Photo: Group photo at the launch Photo: GeneQueens product image Photo: 金因敷 series product picture Photo: The research poster of 肌顏態 at the CSD 2025 Photo 1: 肌顏態 use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University; Photo 2: 肌顏態 use case sharing by Professor Ge Lan, from The First Affiliated Hospital of Army Medical University; Photo 3: Fibronectin clinical trial results sharing by Professor Ye Li, Head of Cosmetics Testing Center at Dermatology Hospital of Southern Medical University; Photo 4: Mr. Du Wei, CEO of Cosmetics News & Cosmetics Business Online, analyzes cosmetics industry development trends Photo: Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, addressing the launch event. Photo: Group photo of the strategic signing ceremony HONG KONG SAR - EQS Newswire - 2 July 2025 - On June 27, 2025, Uni-Bio Science Group Limited (the "Group")grandly held a new medical aesthetics product launch event in Changsha, releasing the high-end series GeneQueens of 肌顏態and the medical device brand 金因敷. Many experts, KOLs and partners attended the event. This launch not only showcased the Group's achievements in R&D, but also marked the comprehensive layout in the "drug, medical device and Aesthetics" the launch, the Group unveiled the high-end series of 肌顏態-——GeneQueens(Human-Sequence Triple Protein Repair & Balance Ampoule). which functions on skin repair and anti-aging. By activating cell regeneration, it helps users restore their youthful and healthy skin a new standard for anti-aging and repair by adding three core ingredients in sufficient quantities. Skbrella FN, as a key ingredient for cell repair, can accelerate the healing of skin wounds and promote the adhesion and migration of new cells. III Collagen strongly fills the skin structure, significantly enhancing elasticity and firmness. XVII Collagen can strengthen the connection between the epidermis and dermis, and consolidate the youthful foundation of the addition, GeneQueens adopts a sterile and preservative-free formula, relying on high-purity raw materials and patented technology, providing users with an "instant enjoyment" precise and efficient experience. Its unique formula and outstanding efficacy were highly recognized by many experts on the the Group also launched several new products of its medical device brand - 金因敷, focusing on the professional repair field of medical aesthetics.金因敷complies with strict clinical trials and quality inspections to ensure its safety and effectiveness. The product adopts a high-purity non-allergenic formula, which can moisturize and accelerate wound repair. It also uses an exclusive cooling technology to relieve postoperative swelling and pain, providing a professional solution for sensitive skin and post-medical procedure is worth mentioning that 肌顏態also showcased the research data of "The Efficacy Study of Fibronectin in the Repair of Skin Barrier Damage for the post-medical procedure" jointly conducted with the Cosmetics Testing Center of the Dermatology Hospital of Southern Medical University in the poster area of the 30th Academic Conference of the Chinese Medical Association (CSD2025). This is not only an endorsement of the Group's research capabilities, but also provides experts and scholars in the industry with an opportunity to gain a deeper understanding of the 肌顏態technology and an annual grand event in the field of dermatology and venereology in China, CSD2025 brings together authoritative experts and scholars in dermatology across the country, presenting multi-dimensional academic achievements and exchanges of ideas. The poster area is one of the core venues of the academic annual conference. Posters are not only an important way for researchers to showcase their scientific research achievements, but also a key link in promoting the dissemination of academic ideas and the feedback of clinical clinical experts at the launch further recognized the significant clinical value of 肌顏態and 金因敷. The experts highlighted that 肌顏態' s patented ingredient, Skbrella FN, demonstrates immense potential in improving damaged sensitive skin barriers, reducing inflammatory erythema, alleviating discomfort sensations such as burning, tightness and itching, as well as enhancing post-laser repair and the clinical observations over the past few months, many patients treated with 肌顏態have achieved remarkable therapeutic effects. The symptoms of anesthetic allergy have been rapidly relieved, the inflammatory pigmentation post-laser has significantly improved, the skin barrier has been repaired, and the patient satisfaction rate is extremely high. 金因敷can effectively reduce redness, swelling and pain for post-medical procedures, accelerate wound healing and shorten the recovery Zhao Zhigang, CEO of Uni-Bio Science Group, emphasized: " We have always adhered to the standards of biopharmaceuticals in creating skin care products. The release of GeneQueens and 金因敷 is an important milestone in building the "Drugs, Medical device and Aesthetics" strategy and creating a full-cycle skin care solution, aiming to meet consumers' increasingly refined skin health needs. "Furthermore, Ms. Liu Yihua, President of Global Cosmetics Group, attended the launch as an important guest. Uni-Bio Science Group and Global Cosmetics Group have jointly established a medical research co-creation biological platform. Utilizing gene-editing biosynthesis technology, the platform has launched Skbrella FN – a highly bioactive recombinant human fibronectin known as "皮優理".The launch also witnessed a grand strategic signing ceremony. The Group has achieved in-depth cooperation with many well-known medical aesthetics chain institutions and well-known agents. This signing is not only a high recognition of the quality and market potential of GeneQueens and 金因敷, but also a key step for the Group to accelerate commercialization and expand channels. Through strong alliances with leading channel partners, the Group will reach the core consumers and ensure the rapid release of huge commercial successful holding of this launch not only marks a crucial step for the Group in medical aesthetics and medical devices, but also demonstrates the Group's in-depth layout and forward-looking vision in the "Drugs, Medical device and Aesthetics" strategy. In the future, the Group will continue to be guided by technology and oriented towards clinical value, accelerate product innovation and technological upgrading, constantly enrich pipeline, and meet the growing market #UniBioScienceGroup The issuer is solely responsible for the content of this announcement.
